Avalo Therapeutics, Inc.

NASDAQ:AVTX

8.81 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012
Omzet 1.92418.0515.3986.6996.7518.32727.8131.1530000.083
Kosten van de omzet 1.2843.4341.4910.311.6297.4780.6368.2390.0249.508.477
Brutowinst 0.6414.6173.9076.399-4.87910.84927.177-7.086-0.024-9.50-8.394
Brutowinstmarge 0.3330.810.7240.955-0.7230.5920.977-6.146000-101.424
Onderzoek- en ontwikkelingskosten 13.78431.30859.83532.19311.7645.7874.37310.156.58712.2418.9148.477
Algemene en administratieve kosten 10.26720.63521.83217.41810.12410.6777.9427.0834.4234.8754.022.097
Verkoop- en marketingkosten 0.0330.0762.8262.3411.4848.5220.97300000
Verkoop-, algemene en administratieve kosten 10.320.71124.65819.75911.60819.1998.9157.0834.4234.8754.022.097
Overige kosten -23.4440.0381.5481.7411.3390.014000000
Bedrijfskosten 0.6452.05786.04153.69324.71129.51813.28817.23311.0117.11612.9342.097
Bedrijfsresultaat -23.444-37.44-82.134-26.953-17.394-39.31413.89-16.08-11.01-17.116-12.934-10.491
Bedrijfsresultaat ratio -12.185-2.074-15.216-4.023-2.577-2.1450.499-13.946000-126.764
Totaal overige inkomsten en kosten netto -8.086-4.19-2.4115.66612.260.055-0.054-0.3920.521.06-0.1110.001
Inkomen voor belasting -31.53-41.63-84.545-67.177-15.991-40.08713.836-16.471-10.49-16.056-13.045-10.49
Inkomen voor belasting ratio -16.388-2.306-15.662-10.028-2.369-2.1870.497-14.285000-126.747
Belastingkosten 0.0140.028-0.196-2.7930.28-0.0341.9670.364-0.544-1.060.1110
Nettowinst -31.544-41.658-84.349-64.384-16.271-40.05311.87-16.471-10.49-16.056-13.045-10.49
Nettowinstmarge -16.395-2.308-15.626-9.611-2.411-2.1850.427-14.285000-126.747
WPA (Winst Per Aandeel) -113.58-1,062.65-2,330.66-2,523.77-819.74-3,317.281,209.6-5,371.95-13,571.8300-199.77
Verwaterde WPA -113.58-1,062.65-2,330.66-2,523.77-819.74-3,317.281,209.6-5,371.95-13,571.8300-199.77
EBITDA -27.955-37.294-80.497-45.451-17.361-13.07214.345-16.053-10.458-17.087-12.914-10.476
EBITDA ratio -14.53-2.073-14.929-3.764-2.5720.3550.516-14.01000-126.582